LONG ACTING OCTREOTIDE IN PTS WITH DISSEMINATED NEUROENDOCRINE TUMORS

被引：0
|
作者：
Markovich, A. [1 ]
Emelianova, G. [1 ]
Gorbounova, V. [1 ]
Bruzgin, V. [1 ]
Orel, N. [1 ]
机构：
[1] NN Blokhin Russian Canc Res Ctr Ramn, Dept Chemotherapy, Moscow, Russia
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：382 / 382
页数：1
相关论文
共 50 条
  • [31] The effect of using long-acting octreotide as adjuvant therapy for patients with grade 2 pancreatic neuroendocrine tumors after radical resection
    Gao Suizhi
    Shi Xiaohan
    Ma Hongyun
    Wang Huan
    Li Bo
    Song Bin
    Guo Shiwei
    Jin Gang
    胰腺病学杂志（英文）, 2020, 03 (04) : 167 - 172
  • [32] Neuroendocrine tumors of the lung and octreotide scintigraphy - Reply
    Tovar, EA
    ANNALS OF THORACIC SURGERY, 2002, 73 (05): : 1693 - 1694
  • [33] Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours
    Koumarianou, Anna
    Antoniou, Stavroula
    Kanakis, George
    Economopoulos, Nikolaos
    Rontogianni, Dimitra
    Ntavatzikos, Anastasios
    Tsavaris, Nikolaos
    Pectasides, Dimitrios
    Dimitriadis, George
    Kaltsas, Gregory
    ENDOCRINE-RELATED CANCER, 2012, 19 (01) : L1 - L4
  • [34] Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
    Clarke, Callisia N.
    Cockrum, Paul
    Beveridge, Thomas J. R.
    Jerry, Michelle
    McMorrow, Donna
    Anh Thu Tran
    Phan, Alexandria T.
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2023, 10 (02): : 121 - 131
  • [35] USE OF LONG-ACTING SOMATOSTATIN ANALOG, LANREOTIDE, IN NEUROENDOCRINE TUMORS
    CANOBBIO, L
    CANNATA, D
    MIGLIETTA, L
    PACE, M
    BOCCARDO, F
    ONCOLOGY REPORTS, 1994, 1 (01) : 129 - 131
  • [36] Octreotide Long-Acting ReleaseTherapy for Patients with Functional and Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Retrospective Analysis in Chang-Gung Memorial Hospital
    Chia-Hsun, H.
    Wen-Chi, C.
    Yung-Chang, L.
    Chaung-Chi, L.
    Rong-Nan, C.
    Cheng-Hsu, W.
    Hung-Chih, H.
    Jen-Shi, C.
    NEUROENDOCRINOLOGY, 2012, 96 : 24 - 24
  • [37] CT evaluation of response in advanced gastroenteropancreatic neuroendocrine tumors treated with long-acting-repeatable octreotide: what is the optimal size variation threshold?
    Luo, Yanji
    Chen, Jie
    Shen, Bingqi
    Wang, Meng
    Cai, Huasong
    Xu, Ling
    Chen, Luohai
    Chen, Minhu
    Li, Zi-Ping
    Feng, Shi-Ting
    EUROPEAN RADIOLOGY, 2018, 28 (12) : 5250 - 5257
  • [38] Impact of Long-Acting Octreotide in Patients with Early-Stage MEN1-Related Duodeno-Pancreatic Neuroendocrine Tumors
    Ramundo, V
    Del Prete, M.
    Marotta, V
    Marciello, F.
    Camera, L.
    Circelli, L.
    Colantuoni, V
    Di Sarno, A.
    Carratu, A. C.
    De Luca di Roseto, C.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 273 - 274
  • [39] CT evaluation of response in advanced gastroenteropancreatic neuroendocrine tumors treated with long-acting-repeatable octreotide: what is the optimal size variation threshold?
    Yanji Luo
    Jie Chen
    Bingqi Shen
    Meng Wang
    Huasong Cai
    Ling Xu
    Luohai Chen
    Minhu Chen
    Zi-Ping Li
    Shi-Ting Feng
    European Radiology, 2018, 28 : 5250 - 5257
  • [40] Everolimus in Combination with Octreotide Long-Acting Repeatable in a First-Line Setting for Patients with Neuroendocrine Tumors: A 5-Year Update
    Bajetta, Emilio
    Catena, Laura
    Pusceddu, Sara
    Spada, Francesca
    Iannacone, Claudio
    Sarno, Italo
    Di Menna, Giandomenico
    Dottorini, Lorenzo
    Marte, Anna Maria
    NEUROENDOCRINOLOGY, 2018, 106 (04) : 307 - 311
12345